Trial intelligence / Profile preview

Tranexamic Acid Oral Solution 5% in Patients on Anticoagulants Undergoing Tooth Extraction

NCT06143787Phase 3Recruiting

Sponsor
Hyloris
Start
Nov 2023
Primary completion
Dec 2024
Modality
Small Molecules
Countries
5
01

Overview

A Phase 3 trial of tranexamic acid in postoperative hemorrhage, sponsored by Hyloris. Started Nov 2023; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT06143787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06143787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call